Taken together, the results provide a convergent body of evidence validating Nexalin’s differentiated, non-invasive approach to treating Alzheimer’s disease. 1. TRANSFORM-AD – Alzheimer’s Research & ...

Hz DIFS™ significantly improves cognitive performance and brain connectivity in peer-reviewed clinical trial Results published in Radiology, ...

Age-related macular degeneration (AMD) causes progressive vision loss in many elderly people, and no treatment is available ...

Nexalin's Sync neurostimulation device uses a specific electrical waveform to increase hippocampal-cortical connectivity. The device has already been approved in China to treat depression and insomnia ...

Medical device maker Boston Scientific said on Friday it will buy the remaining equity in privately held Nalu Medical for ...

A new surgically implanted device the size of a lima bean can help control rheumatoid arthritis that isn't responding to ...

The $9.9 million research project will allow a dozen amputees to test a neural-controlled prosthesis that sends touch ...